PHASE 1 SAFETY LEAD-IN AND RANDOMIZED OPENLABEL PERIOPERATIVE STUDY OF VORASIDENIB COMBINED WITH PEMBROLIZUMAB IN RECURRENT OR PROGRESSIVE ENHANCING IDH1-MUTANT ASTROCYTOMAS: SAFETY LEAD-IN RESULTS-MedSci.cn

PHASE 1 SAFETY LEAD-IN AND RANDOMIZED OPENLABEL PERIOPERATIVE STUDY OF VORASIDENIB COMBINED WITH PEMBROLIZUMAB IN RECURRENT OR PROGRESSIVE ENHANCING IDH1-MUTANT ASTROCYTOMAS: SAFETY LEAD-IN RESULTS

Wen, P; Peters, K; de la Fuente, M; Mellinghoff, I; Arrillaga-Romany, I; Kumthekar, P; Clarke, J; Puduvalli, V; de Groot, J; Zhang, XM; Chisamore, M; Abshire, M; Mahboub, P; Hassan, I; Knipstein, J; Cloughesy, T

NEURO-ONCOLOGY, 2023; 25 ():

科室
- - 订阅+
  - 更多科室
工具
服务